AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Interview with Dr. Anthony Fauci on “Mississippi Baby”

Dr. Fauci

In an important announcement yesterday, Thursday, July 10, the National Institutes of Health (NIH) reported that the child known as the “Mississippi Baby”—an infant seemingly cured of HIV after treatment had been initiated within hours of birth—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of the…

“Mississippi Baby” Now Has Detectable HIV, Researchers Find

nih logo

The child known as the “Mississippi baby”—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable levels of HIV after more than two years of not taking antiretroviral therapy without evidence of virus, according to the pediatric…

National HIV Testing Day, June 27, 2014

NIH logo

Transmission of HIV continues at an unacceptably high rate, and drug use plays an important role—both through exposure to infected body fluids among injection drug users and through the lowered inhibition and risky sexual behaviors that all forms of drug use facilitate. Almost 1.1 million Americans are currently living with the HIV virus, and nearly…

NIH Seeks Applications for HIV and Viral Hepatitis Co-Infection Research Funding

Ronald Valdiserri

The National Institutes of Health (NIH) recently released two funding opportunity announcements (FOAs) to support multidisciplinary studies of HIV and viral hepatitis co-infection. The opportunities were issued under NIH’s R01 or Research Project Grant program and R21 or Exploratory/Developmental Research Grant program. NIH notes that the FOAs were informed by priority areas in the Action…

NIDA 2014 Avant-Garde Award for HIV/AIDS Research

NIDA arp

This week, the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced the 2014 Avant-Garde Awards for HIV/AIDS research. According to a NIDA press release, the awards offer hope in battling HIV infection and improving long-term outcomes in HIV-infected drug users. With proposals ranging from enhancing the immune system’s ability…

HIV Vaccine Awareness Day

Dr. Anthony Fauci

Watch NIAID Director Anthony S. Fauci, M.D., discuss current HIV vaccine research approaches. Developing a safe and sufficiently effective HIV vaccine is essential if we are to achieve a timely and durable end to the global HIV/AIDS pandemic. The path to an HIV vaccine has not been—and will not be—an easy one. In the 27…

Public Health Grand Rounds Focuses on PrEP for HIV Prevention

prep cdc grandrounds

The Public Health Grand Rounds, sponsored by the Centers for Disease Control and Prevention (CDC), will explore the science base for using oral pre-exposure prophylaxis (PrEP) as a tool to prevent the transmission of HIV, on Tuesday, May 20, at 1:00pm ET. The Grand Rounds is available by live webcast and on Twitter using the…

Just-Released Guidelines: Pre-Exposure Prophylaxis Use for HIV Prevention

CDC thumbnail of prep video

Today, the U.S. Public Health Service and the Centers for Disease Control and Prevention released guidelines for the use of daily oral antiretroviral pre-exposure prophylaxis, or PrEP, for HIV infection, entitled: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 [PDF 867KB]. These guidelines provide health care providers with recommendations on…